Clinical trial reportEndocrine-related cancerPublished
Cabozantinib for advanced grade 3 neuroendocrine tumors: subgroup analysis of the phase 3 CABINET trial (Alliance A021602)
Regional connection
Verified An author affiliation on the Europe PMC record names Fox Chase Cancer Center, with Temple Health linked by the institution reference. Affiliation source
- Institutions
- Fox Chase Cancer Center, Temple Health
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Endocrine-related cancer
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Neuroendocrine Tumors; Anilides; Pyridines; Antineoplastic Agents; Adult; Aged; Middle Aged; Female; Male; Neoplasm Grading; Pancreatic Neuroendocrine Tumor
- PubMed ID
- 41524552
- PubMed Central ID
- PMC12872296
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked